Suppr超能文献

转录因子的协同结合调控重编程。

Cooperative Binding of Transcription Factors Orchestrates Reprogramming.

作者信息

Chronis Constantinos, Fiziev Petko, Papp Bernadett, Butz Stefan, Bonora Giancarlo, Sabri Shan, Ernst Jason, Plath Kathrin

机构信息

David Geffen School of Medicine, Department of Biological Chemistry, University of California Los Angeles, Los Angeles, CA 90095, USA; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, Jonsson Comprehensive Cancer Center, Bioinformatics Program, Los Angeles, CA 90095, USA.

David Geffen School of Medicine, Department of Biological Chemistry, University of California Los Angeles, Los Angeles, CA 90095, USA; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, Jonsson Comprehensive Cancer Center, Bioinformatics Program, Los Angeles, CA 90095, USA.

出版信息

Cell. 2017 Jan 26;168(3):442-459.e20. doi: 10.1016/j.cell.2016.12.016. Epub 2017 Jan 19.

Abstract

Oct4, Sox2, Klf4, and cMyc (OSKM) reprogram somatic cells to pluripotency. To gain a mechanistic understanding of their function, we mapped OSKM-binding, stage-specific transcription factors (TFs), and chromatin states in discrete reprogramming stages and performed loss- and gain-of-function experiments. We found that OSK predominantly bind active somatic enhancers early in reprogramming and immediately initiate their inactivation genome-wide by inducing the redistribution of somatic TFs away from somatic enhancers to sites elsewhere engaged by OSK, recruiting Hdac1, and repressing the somatic TF Fra1. Pluripotency enhancer selection is a stepwise process that also begins early in reprogramming through collaborative binding of OSK at sites with high OSK-motif density. Most pluripotency enhancers are selected later in the process and require OS and other pluripotency TFs. Somatic and pluripotency TFs modulate reprogramming efficiency when overexpressed by altering OSK targeting, somatic-enhancer inactivation, and pluripotency enhancer selection. Together, our data indicate that collaborative interactions among OSK and with stage-specific TFs direct both somatic-enhancer inactivation and pluripotency-enhancer selection to drive reprogramming.

摘要

八聚体结合转录因子4(Oct4)、性别决定区Y框蛋白2(Sox2)、 Kruppel样因子4(Klf4)和原癌基因c-Myc(OSKM)可将体细胞重编程为多能性细胞。为了从机制上理解它们的功能,我们绘制了在离散重编程阶段的OSKM结合、阶段特异性转录因子(TFs)和染色质状态图谱,并进行了功能丧失和功能获得实验。我们发现,在重编程早期,OSK主要结合活跃的体细胞增强子,并通过诱导体细胞TFs从体细胞增强子重新分布到OSK结合的其他位点、招募组蛋白去乙酰化酶1(Hdac1)以及抑制体细胞TF Fra1,立即在全基因组范围内启动它们的失活。多能性增强子的选择是一个逐步的过程,也在重编程早期通过OSK在具有高OSK基序密度的位点的协同结合开始。大多数多能性增强子在这个过程的后期被选择,并且需要OS和其他多能性TFs。当体细胞TFs和多能性TFs过表达时,它们通过改变OSK靶向、体细胞增强子失活和多能性增强子选择来调节重编程效率。总之,我们的数据表明,OSK之间以及与阶段特异性TFs的协同相互作用指导体细胞增强子失活和多能性增强子选择,从而驱动重编程。

相似文献

1
Cooperative Binding of Transcription Factors Orchestrates Reprogramming.转录因子的协同结合调控重编程。
Cell. 2017 Jan 26;168(3):442-459.e20. doi: 10.1016/j.cell.2016.12.016. Epub 2017 Jan 19.
6
ΔNp63 regulates select routes of reprogramming via multiple mechanisms.ΔNp63 通过多种机制调控重编程的特定途径。
Cell Death Differ. 2013 Dec;20(12):1698-708. doi: 10.1038/cdd.2013.122. Epub 2013 Sep 6.

引用本文的文献

1
Epigenetic Regulation of Aging and its Rejuvenation.衰老及其逆转的表观遗传调控
MedComm (2020). 2025 Sep 1;6(9):e70369. doi: 10.1002/mco2.70369. eCollection 2025 Sep.
3
Mouse and human embryonic genome activation initiate at the one-cell stage.小鼠和人类胚胎基因组激活始于单细胞阶段。
Front Cell Dev Biol. 2025 Jul 30;13:1594995. doi: 10.3389/fcell.2025.1594995. eCollection 2025.

本文引用的文献

3
The oncogene c-Jun impedes somatic cell reprogramming.癌基因 c-Jun 阻碍体细胞核重编程。
Nat Cell Biol. 2015 Jul;17(7):856-67. doi: 10.1038/ncb3193. Epub 2015 Jun 22.
6
The selection and function of cell type-specific enhancers.细胞类型特异性增强子的选择与功能。
Nat Rev Mol Cell Biol. 2015 Mar;16(3):144-54. doi: 10.1038/nrm3949. Epub 2015 Feb 4.
8
HTSeq--a Python framework to work with high-throughput sequencing data.HTSeq——一个用于处理高通量测序数据的Python框架。
Bioinformatics. 2015 Jan 15;31(2):166-9. doi: 10.1093/bioinformatics/btu638. Epub 2014 Sep 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验